ATE498413T1 - Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat - Google Patents

Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat

Info

Publication number: ATE498413T1
Authority: AT; Austria
Prior art keywords: amino acids; sodium hyaluronate; wound healing; powder based; sterile powder
Prior art date: 2005-10-26

Application number

AT06806305T

Other languages

English (en)

Inventor

Franco Conti

Francesco Saverio Dioguardi

Original Assignee

Professional Dietetics Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-26

Filing date

2006-10-16

Publication date

2011-03-15

2006-10-16 Application filed by Professional Dietetics Srl filed Critical Professional Dietetics Srl

2011-03-15 Application granted granted Critical

2011-03-15 Publication of ATE498413T1 publication Critical patent/ATE498413T1/de

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
150000001413 amino acids Chemical class 0.000 title abstract 2
239000000843 powder Substances 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
230000029663 wound healing Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT06806305T 2005-10-26 2006-10-16 Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat ATE498413T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT002037A ITMI20052037A1 (it)	2005-10-26	2005-10-26	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
PCT/EP2006/009968 WO2007048524A2 (en)	2005-10-26	2006-10-16	Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate

Publications (1)

Publication Number	Publication Date
ATE498413T1 true ATE498413T1 (de)	2011-03-15

Family

ID=37903460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06806305T ATE498413T1 (de)	2005-10-26	2006-10-16	Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat

Country Status (11)

Country	Link
US (2)	US20080261915A1 (de)
EP (1)	EP1940478B1 (de)
JP (1)	JP5334584B2 (de)
KR (1)	KR101367340B1 (de)
AT (1)	ATE498413T1 (de)
CA (1)	CA2627223C (de)
DE (1)	DE602006020155D1 (de)
ES (1)	ES2357415T3 (de)
IT (1)	ITMI20052037A1 (de)
PT (1)	PT1940478E (de)
WO (1)	WO2007048524A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
ITMI20052036A1 (it)	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
IT1396935B1 (it)	2009-11-26	2012-12-20	Solartium Entpr Ltd	Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397522B1 (it) *	2009-12-21	2013-01-16	Solartium Entpr Ltd	Uso di una combinazione per il trattamento dell'osteoartrosi
ITMI20110954A1 (it) *	2011-05-26	2012-11-27	Professional Dietetics Srl	Combinazioni per il trattamento delle mucositi vaginali o rettali
CN111748071B (zh) *	2020-06-29	2022-03-01	武汉瑞法医疗器械有限公司	一种亲水性聚氨酯泡沫敷料及其制备方法
IT202400006397A1 (it) *	2024-03-22	2025-09-22	The Wave Innovation Group S R L	Una composizione a base di acido ialuronico e amminoacidi per l’uso nel trattamento di ferite paradontali

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1165243A (en) *	1980-02-19	1984-04-10	Anthony N. Silvetti	Method and composition for treatment of wounds
US4707354A (en) *	1985-06-17	1987-11-17	Alpen Tau, Inc.	Mature skin treatment and protectant compositions and methods of using same
WO1996003158A1 (en) *	1994-07-22	1996-02-08	Alcon Laboratories, Inc.	Use of low molecular weight amino acids in ophthalmic compositions
US6541460B2 (en) *	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
US6645948B2 (en) *	1998-03-24	2003-11-11	George D. Petito	Nutritional composition for the treatment of connective tissue
IT1318556B1 (it) *	2000-06-07	2003-08-27	Solartium Establishment	Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
FR2820635B1 (fr) *	2001-02-09	2005-01-21	Genevrier Lab	Procede de preparation d'une creme a base d'acide hyaluronique
ITTO20010804A1 (it) *	2001-08-08	2003-02-08	Professional Dietetics Srl	Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
US20040265268A1 (en) *	2001-08-18	2004-12-30	Deepak Jain	Compositions and methods for skin rejuvenation and repair
US6780841B2 (en) *	2001-11-13	2004-08-24	Biocell Technology, Llc	Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20040180025A1 (en) *	2003-03-12	2004-09-16	New Life Resources, Llc	Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
FR2864445B1 (fr) *	2003-12-30	2006-04-28	Jean Noel Thorel	Utilisation topique d'une base nutritive complexe
ITMI20052036A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato

2005
- 2005-10-26 IT IT002037A patent/ITMI20052037A1/it unknown
2006
- 2006-09-16 US US12/091,551 patent/US20080261915A1/en not_active Abandoned
- 2006-10-16 EP EP06806305A patent/EP1940478B1/de not_active Not-in-force
- 2006-10-16 PT PT06806305T patent/PT1940478E/pt unknown
- 2006-10-16 JP JP2008536975A patent/JP5334584B2/ja not_active Expired - Fee Related
- 2006-10-16 ES ES06806305T patent/ES2357415T3/es active Active
- 2006-10-16 WO PCT/EP2006/009968 patent/WO2007048524A2/en not_active Ceased
- 2006-10-16 KR KR1020087009862A patent/KR101367340B1/ko not_active Expired - Fee Related
- 2006-10-16 AT AT06806305T patent/ATE498413T1/de active
- 2006-10-16 CA CA2627223A patent/CA2627223C/en not_active Expired - Fee Related
- 2006-10-16 DE DE602006020155T patent/DE602006020155D1/de active Active
2010
- 2010-12-09 US US12/964,419 patent/US8426384B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR101367340B1 (ko)	2014-02-28
JP2009513587A (ja)	2009-04-02
WO2007048524A3 (en)	2008-01-31
JP5334584B2 (ja)	2013-11-06
DE602006020155D1 (de)	2011-03-31
US20110077218A1 (en)	2011-03-31
EP1940478B1 (de)	2011-02-16
ITMI20052037A1 (it)	2007-04-27
ES2357415T3 (es)	2011-04-26
EP1940478A2 (de)	2008-07-09
US8426384B2 (en)	2013-04-23
PT1940478E (pt)	2011-03-07
CA2627223C (en)	2014-04-08
WO2007048524A2 (en)	2007-05-03
CA2627223A1 (en)	2007-05-03
KR20080065982A (ko)	2008-07-15
US20080261915A1 (en)	2008-10-23

Legal Events

Date

Code

Title

Description

2011-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1940478

Country of ref document: EP

Publication	Publication Date	Title
ATE451916T1 (de)	2010-01-15	Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat
ATE451100T1 (de)	2009-12-15	Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat
CY1118038T1 (el)	2017-05-17	Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος
UA94734C2 (ru)	2011-06-10	ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
BR112012017054A2 (pt)	2016-11-22	"análogo de peptídeo de oxintomodulina, seu uso, bem como composição farmacêutica"
IL222880A (en)	2015-08-31	Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
DE50203788D1 (de)	2005-09-01	Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung
BR0108173A (pt)	2003-01-21	Composições farmacêuticas de toxina de botulina
BRPI0809583A2 (pt)	2019-09-03	polipeptídeos fgf-21 modificados e seus usos
CY1112682T1 (el)	2016-02-10	Ενεργες παραλλαγες της πρωτεϊνης προσδεσης il-18 και ιατρικες χρησεις αυτων
ATE489371T1 (de)	2010-12-15	Benzamidglucokinaseaktivatoren
GB2492935A (en)	2013-01-16	Conjugated blood coagulation factor VIII
MX2012002785A (es)	2012-04-11	Derivado de indenona y composicion farmaceutica que comprende el mismo.
AR077139A1 (es)	2011-08-03	Composiciones farmaceuticas utiles para tratar el vch
CL2007003209A1 (es)	2008-05-09	Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion
ATE458746T1 (de)	2010-03-15	Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
BRPI0607198A2 (pt)	2016-11-01	composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
CY1109537T1 (el)	2014-08-13	Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
CY1115961T1 (el)	2017-01-25	Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
CY1117854T1 (el)	2017-05-17	Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
IL173852A (en)	2013-04-30	High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
DE602006020155D1 (de)	2011-03-31	Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
ATE529096T1 (de)	2011-11-15	Pharmazeutische zusammensetzungen mit bradykinin- antagonisten und hyaluronsäure sowie anwendungen davon
BRPI0508596A (pt)	2007-08-21	combinação compreendendo ligante alfa-2-delta
ZA200804163B (en)	2009-10-28	New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions